In experimental studies in pigs, it was shown that the first intravenous injection of potent equine antiporcine thymocyte globulin (ATG) induced a symptomatic anaphylactic reaction which was accompanied by high plasma histamine and serotonin levels, depletion of the peripheral stores of these compounds and a pronounced lymphopenia. A refractory state followed in which further ATG injections did not induce such reactions. Patients treated with equine antihuman ATG had a similar reaction and refractory period. Antihistamine therapy was both prophylactic and effective in reversing the symptoms. It is suggested that the symptomatic anaphylactic reaction observed was due to reverse type anaphylaxis caused by an antigen antibody reaction (ATG + lymphocyte) in which pharmacological mediators were released. It was demonstrated experimentally that the refractory state was attributed to the absence of sufficient numbers of ATG sensitive lymphocytes during the subsequent injections. Depressed serum complement levels and a reduced store of histamine and serotonin observed in the experimental animals may have participated toward the induction of the refractory period. It is recommended that reverse anaphylaxis be considered when an acute reaction is observed in patients who have no evidence of antibodies to horse proteins.

This content is only available via PDF.
© 1971 S. Karger AG, Basel
1971
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.